Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor

Fredrik Anesten, Adrià Dalmau Gasull, Jennifer E. Richard, Imre Farkas, Devesh Mishra, Lilly Taing, Fuping Zhang, Matti Poutanen, Vilborg Palsdottir, Zsolt Liposits, Karolina P. Skibicka, John Olov Jansson

Research output: Contribution to journalArticle

Abstract

Neuronal circuits involving the central amygdala (CeA) are gaining prominence as important centres for regulation of metabolic functions. As a part of the subcortical food motivation circuitry, CeA is associated with food motivation and hunger. We have previously shown that interleukin (IL)-6 can act as a downstream mediator of the metabolic effects of glucagon-like peptide-1 (GLP-1) receptor (R) stimulation in the brain, although the sites of these effects are largely unknown. In the present study, we used the newly generated and validated RedIL6 reporter mouse strain to investigate the presence of IL-6 in the CeA, as well as possible interactions between IL-6 and GLP-1 in this nucleus. IL-6 was present in the CeA, mostly in cells in the medial and lateral parts of this structure, and a majority of IL-6-containing cells also co-expressed GLP-1R. Triple staining showed GLP-1 containing fibres co-staining with synaptophysin close to or overlapping with IL-6 containing cells. GLP-1R stimulation enhanced IL-6 mRNA levels. IL-6 receptor-alpha (IL-6Rα) was found to a large part in neuronal CeA cells. Using electrophysiology, we determined that cells with neuronal properties in the CeA could be rapidly stimulated by IL-6 administration in vitro. Moreover, microinjections of IL-6 into the CeA could slightly reduce food intake in vivo in overnight fasted rats. In conclusion, IL-6 containing cells in the CeA express GLP-1R, are close to GLP-1-containing synapses, and demonstrate increased IL-6 mRNA in response to GLP-1R agonist treatment. IL-6, in turn, exerts biological effects in the CeA, possibly via IL-6Rα present in this nucleus.

Original languageEnglish (US)
Article numbere12722
JournalJournal of Neuroendocrinology
Volume31
Issue number6
DOIs
StatePublished - Jun 2019

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor'. Together they form a unique fingerprint.

  • Cite this

    Anesten, F., Dalmau Gasull, A., Richard, J. E., Farkas, I., Mishra, D., Taing, L., Zhang, F., Poutanen, M., Palsdottir, V., Liposits, Z., Skibicka, K. P., & Jansson, J. O. (2019). Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor. Journal of Neuroendocrinology, 31(6), [e12722]. https://doi.org/10.1111/jne.12722